发明名称 Prevention and treatment of amyloid-associated disorders
摘要 The present invention provides assays to identify compounds that affect microglial cell activation, and specifically assays to identify compounds that affect secretion of cytokines from these microglial cells by modulating PGE<SUB>2</SUB>-mediated activity. The assays of the invention include assays for testing microglial cell activation by contacting microglia with compounds that modulate beta-amyloid PGE<SUB>2</SUB>-mediated activation, which can be identified by cellular activity such as secretion of cytokines, e.g., TNF-alpha and IL-1alpha,. The effect of the candidate compound can be determined by comparing the effect with a control culture which is not contacted with the compound, or by comparing the effect with a standardized profile.
申请公布号 AU5908300(A) 申请公布日期 2001.01.22
申请号 AU20000059083 申请日期 2000.06.30
申请人 SCIOS INC.;ELI LILLY AND COMPANY 发明人 PAUL ANDREW HYSLOP;FOY DEAN MILLER;LINDA S. HIGGINS;ROSANNE CATALANO;BARBARA CORDELL;ELZBIETA PUCHACZ
分类号 A61K45/00;A61P25/28;C12Q1/02;G01N33/15;G01N33/50;G01N33/68 主分类号 A61K45/00
代理机构 代理人
主权项
地址